Creoscg Obtains Domestic Patent for Recombinant VSV-Based COVID-19 Vaccine
Predicted impact: Low
Domestic patent for a COVID-19 vaccine platform; early-stage and small for CreoSG.
CreoSG크레오에스지
040350 · KOSDAQ · ₩040350 · 크레오에스지
₩2,505▼ ₩10 (0.40%)End-of-day · Oct 30, 2026 · End-of-day prices.
CREOSG acquires additional Q-Holdings shares for ₩8.1B
Predicted impact: Low· Actual: −9.0% vs sector, volume 0.5× normal (5 trading days)
₩8.1B share purchase is about 13% of CreoSG's market value, but a stake in another company.
Curo Holdings to Raise ₩8.1B Through Rights Offering; Third-Party Allotment to CreoSG
Predicted impact: Low· Actual: −9.0% vs sector, volume 0.5× normal (5 trading days)
Rights offering of about 8.1 billion won is small versus the roughly 61 billion won market value.
Also known as: CreoSG / 크레오에스지 / 040350 / KRX:040350
Source: KRX statistical information